Abstract: The present disclosure discloses a method, a system and a computer program product for secure data communication between a user device and a server. User credentials, a device id and a first hash are received at server from a user device. The first hash is generated using the user credentials. At server, a second hash is computed using the user credentials stored in the database of the server. The first hash is verified with the second hash. Once verified, an encryption key and a sequence number corresponding to the user credentials and device id are generated. The encryption key and the sequence number are encrypted using a pre-defined key and one or more user credentials. The encrypted encryption key and the sequence number are sent to the user device to encrypt data.

Abstract: The present disclosure discloses a method, a system and a computer program product for secure data communication between a user device and a server. User credentials, a device id and a first hash are received at server from a user device. The first hash is generated using the user credentials. At server, a second hash is computed using the user credentials stored in the database of the server. The first has is verified with the second hash. Once verified, an encryption key and a sequence number corresponding to the user credentials and device id are generated. The encryption key and the sequence number are encrypted using a pre-defined key and one or more user credentials. The encrypted encryption key and the sequence number are sent to the user device to encrypt data.

Abstract: The present invention relates to computer-implemented methods, systems and computer-readable media for providing financial transactions. The method steps comprise initializing at least one transaction from a customer held device, wherein initializing comprises entering a network provider code, an acquiring institution number, a merchant identification number, a terminal identification number and sending a transaction request to an issuing institution. The method further comprises authenticating said transaction by said issuing institution, wherein authenticating comprises confirming said transaction by said issuing institution, sending said confirmation transaction to an acquiring institution and routing the confirmation to said terminal identification number by said acquiring institution and terminating said transaction at a merchant held device.

Abstract: The invention discloses a method, system and computer program product for making secure payments. A customer selects one or more items to be purchased. The customer then enters an authentication detail and a dynamic password, also referred to as a One Time Password (OTP), on an Electronic Data Capture device for authenticating the payment. Based on the authenticity of the OTP and the authentication details, a payment request is sent to an organization for completing the payment.

Abstract: The present invention discloses a method, system and computer program product for registering a customer with an organization to enable the customer to use various services through one or more delivery channels. Customer Relationship Information (CRI) and contact information of the customer is captured by the system. A confirmation number is communicated to the customer based on the validity of the CRI. The customer then submits the confirmation number to the system to complete the registration process. The registration is then confirmed based on the validity of the submitted confirmation number.

Abstract: The present invention provides a method of treating acute and chronic myeloid leukemia (AML & CML) and lymphoid leukemia, said method comprising administering a pharmaceutical composition comprising pharmaceutically effective amount of chlorogenic acid (CA) and 3-o-p-Coumaryl quinic acid (PCQ) isolated from any plant parts of Piper betel or any other source, both individually or in a synergistic combination optionally along with pharmaceutically acceptable additives.

Abstract: This invention relates to a pharmaceutical composition useful for treating chronic myeloid leukemia where Bcr-Abl kinase is constitutively expressed in animals and humans, and a treatment of chronic myeloid leukemia (CML) by a composition comprising an effective amount of analogs and/or salts of chlorogenic acid. The analogs are preferably sodium chlorogenate (Na-Chl) or potassium or ammonium salts, which were prepared from Chlorogenic acid or its analogs.

Abstract: This invention relates to a pharmaceutical composition useful for treating chronic myeloid leukemia where Bcr-Abl kinase is constitutively expressed in animals and humans, and a treatment of chronic myeloid leukemia (CML) by a composition comprising an effective amount of analogs and/or salts of chlorogenic acid. The analogs are preferably sodium chlorogenate (Na-Chl) or potassium or ammonium salts, which were prepared from Chlorogenic acid or its analogs.

Abstract: The present invention provides a method of treating acute and chronic myeloid leukemia (AML & CML) and lymphoid leukemia, said method comprising administering a pharmaceutical composition comprising pharmaceutically effective amount of chlorogenic acid (CA) and 3-o-p-Coumaryl quinic acid (PCQ) isolated from any plant parts of Piper betel or any other source, both individually or in a synergistic combination optionally along with pharmaceutically acceptable additives.

Abstract: A new herbal-based composition and method for treatment of CD33+ acute and chronic myeloid leukemia by Piper betel leaf extracts, and to provide a process for the isolation of active fractions from leaves or any other plant parts of Piper betel to treat CD3 3+ AML and CML with a simplified method of isolation of active components from all plant parts of Piper betel possessing biological activities relevant to the treatment of CD33+ AML and CML.

Abstract: The present invention relates to a pharmaceutical composition useful for treating chronic myeloid leukemia where Bcr-Abl kinase is constitutively expressed in animals and humans, said composition comprising an effective amount of analogs of chlorogenic acid such as neochlorogenic acid (5-O-caffeoyl quinic acid), cryptochlorogenic acid (4-O-Caffeoyl quinic acid), 3-O-(3′-methylcaffeoyl) quinic acid and 5-O-(Caffeoyl-4′-methyl) quinic acid and/or its salts such as sodium, potassium and ammonium together with pharmaceutically acceptable additives.

Abstract: The present invention relates to a new use of the compound chlorogenic acid isolated from the piper betel leaf extract or from any other sources for the treatment of acute and chronic myeloid leukemia and lymphoid leukemia, and the present invention also provides a pharmaceutical composition comprising chloregenic acid along with pharmaceutically acceptable additive for the treatment of acute and chronic myeloid leukemia and lymphoid leukemia.

Abstract: A method for making a tantala/silica interference filter on a vitreous substrate, which filter retains integrity at temperatures in excess of 600.degree. C., includes the steps of depositing by low pressure chemical vapor deposition a first coating of tantala/silica on the substrate, heat treating the first coating, and depositing by low pressure chemical vapor deposition a second coating of tantala/silica, the first and second coatings in combination providing a tantala/silica interference filter with a thickness of at least 3.5 microns on the vitreous substrate. There is further presented an electric lamp having an envelope and an interference filter applied thereto, in accordance with the above method.

Abstract: A method for making a tantala/silica interference filter on a vitreous substrate, the filter retaining integrity at temperatures in excess of 600.degree. C., includes the steps of applying to the vitreous substrate a first coating of vitreous silica doped with submicron-sized particles, depositing on the first coating by low pressure chemical vapor deposition the filter which comprises a second coating comprising alternating layers of tantala and silica, and heat treating the substrate and first and second coatings to bond the filter to the substrate. There is further provided an electric lamp having an envelope made in accordance with the above method.

Abstract: A method for making a tantala/silica interference filter on a vitreous substrate, the filter retaining integrity at temperatures in excess of 600.degree. C., includes the steps of applying to the vitreous substrate a first coating of vitreous silica doped with submicron-sized particles, depositing on the first coating by low pressure chemical vapor deposition the filter which comprises a second coating comprising alternating layers of tantala and silica, and heat treating the substrate and first and second coatings to bond the filter to the substrate. There is further provided an electric lamp having an envelope made in accordance with the above method.

Abstract: A method of producing crack free ceramic parts having large cross-sections is disclosed. An initial mixture of ceramic powder containing a binder and from 0.1 v/o to 10 v/o of whiskers or fibers which are made of carbon, graphite or high temperature melting or decomposition point organic polymers. The mixture is either injection molded or slip cast to form a shaped article. The shaped article is heated in a nitrogen atmosphere to a temperature of 450.degree. C. and then in an atmosphere of air at a temperature of 450.degree. C. to 600.degree. C. to completely remove the binder. The resulting binderless shaped article is then heated at 800.degree. C. for a period of time sufficient to completely remove the whiskers or fibers from the shaped articles. The article is then encapsulated in glass and hot isostatically pressed at a pressure of 30,000 psi to densify the article to approximately 99% of theoretical. The resulting article has a complex geometry and a large cross-section but without detrimental cracks.

Abstract: A method for fabricating large, greater than one centimeter cross section, high density silicon nitride by injection molding process has been developed. The method requires use of a controlled starting powder, a novel binder removal process, a prefiring step followed by isopressing and conventional sintering.

Abstract: A method for fabricating injection molded ceramic shapes suitable for densification by sintering or hot isostatic pressing has been developed. The method is applicable to ceramic articles of large, complex cross sections, greater than one centimeter, which are generally prone to external cracking during binder removal. The method requires use of a controlled starting powder, and a novel binder removal process to obtain an externally crack-free article.

Abstract: Nuclear waste is formed into a substantially water-insoluble solid for temporary storage and transportation by mixing the calcined waste with at least 10 weight percent powdered anhydrous sodium silicate to form a mixture and subjecting the mixture to a high humidity environment for a period of time sufficient to form cementitious bonds by chemical reaction. The method is suitable for preparing an interim waste form from dried high level radioactive wastes.

Abstract: Porous, rigid separators for electrochemical cells are prepared by first calcining particles of ceramic material at temperatures above about 1200.degree. C. for a sufficient period of time to reduce the sinterability of the particles. A ceramic powder that has not been calcined is blended with the original powder to control the porosity of the completed separator. The ceramic blend is then pressed into a sheet of the desired shape and sintered at a temperature somewhat lower than the calcination temperature. Separator sheets of about 1 to 2.5 mm thickness and 30 to 70% porosity can be prepared by this technique. Ceramics such as yttria, magnesium oxide and magnesium-aluminum oxide have advantageously been used to form separators by this method.